Aspirin Deprescribing Guidelines
For practitionersEVAL Foundation
Patient-specific recommendations to change or discontinue aspirin that may lead to fewer adverse events
Collection
EVAL Foundation
Patient-specific recommendations to change or discontinue aspirin that may lead to fewer adverse events
EVAL Foundation
Calculates body mass index and body surface area (Mosteller formula).
EVAL Foundation
Corrects the QT interval for heart rate extremes (includes Bazett, Fridericia, Framingham, Hodges & Rautaharju formulas.
EVAL Foundation
Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care
EVAL Foundation
Predicts 6-week rise of major adverse cardiac events.
EVAL Foundation
Quantifies risk of hemorrhage in elderly patients with AFib
EVAL Foundation
LDL calculation from total cholesterol, HDL and triglycerides.
EVAL Foundation
Calculates mean arterial pressure
OSU Center for Health Sciences
Review of symptoms to assess for exertional leg symptoms, lower extremity rest pain and physical signs suggestive of PAD
OSU Center for Health Sciences
Validated instrument for the assessment of health-related quality of life in peripheral arterial disease (PAD).
EVAL Foundation
Estimates risk of cardiac complications after noncardiac surgery
EVAL Foundation
Screens for obstructive sleep apnea
OSU Center for Health Sciences
Noninvasive physiological test used for the initial diagnosis and monitoring of peripheral arterial disease.
EVAL Foundation
Calculates risk of DVT